Skip to content

The Impact of Goode Health Beverage on Markers of Physiological and Neurocognitive Health

The Impact of Goode Health Beverage on Markers of Physiological and Neurocognitive

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06245382
Enrollment
22
Registered
2024-02-07
Start date
2023-10-01
Completion date
2024-12-31
Last updated
2025-04-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cardiovascular Diseases, Cognitive Decline, Diet, Healthy, Hypertension

Keywords

endothelial function, brain blood flow, cognition

Brief summary

The overall research objective of this proposal is to determine the acute and chronic impact of daily supplementation of a Good Health beverage on indices of physiological and neurocognitive health.

Detailed description

Cardiovascular disease (CVD) is the leading cause of morbidity and mortality and affects all individuals. There are many primary risk factors for CVD with some of the primary causes including hypertension, hypercholesteremia, atherosclerosis, and type 2 diabetes mellitus. Furthermore, the rise in the prevalence of various neurocognitive conditions and cerebral vascular diseases including cognitive dysfunction, dementia, stroke, and Alzheimer's disease requires additional attention from a research perspective. While the reasons contributing to CVD and neurocognitive complications/cerebral vascular diseases, is multifactorial, a common link is impaired vascular function. A hallmark of impaired vascular function is elevated arterial stiffness and a decrease in the vasodilator capacity in the brain and periphery. Reduced nitric oxide (NO) bioavailability, due to elevated oxidative stress and systemic inflammation is implicated as a primary contributing factor for these attenuated vasodilatory responses. Therefore, it is reasonable to speculate that an approach targeting these pathways could abolish or minimize this elevated risk. One such approach could be increased dietary consumption of a naturally based product that is high in polyphenol content and ingredients that are well-known to have beneficial effects on oxidative stress, inflammation, blood lipids etc. In turn this would be expected to have beneficial outcomes on various biomarkers associated with peripheral and cerebral vascular health including, cholesterol, lipid profile, insulin sensitivity/type II diabetes, cognitive health, arterial stiffness, blood pressure, and NO bioavailability and subsequently vascular function/health. Specifically, the Goode Health Super Food Smoothie Blend is a product that we are interested in investigating in this proposal. 1. Primary Aim - The primary endpoint is the effect of increased daily consumption of the Good Health beverage on outcomes associated with elevated risk for various neurocognitive and pathophysiological conditions/diseases. These outcomes include cognitive function, central and peripheral arterial blood pressure, cerebral and peripheral blood vessel function/health, and blood biomarkers (e.g., indices of inflammation, oxidative stress, insulin resistance/diabetes risk, and lipid profile). 2. Secondary Aim - A secondary endpoint is the effect of daily consumption of the Good Health beverage on the following variables: waist circumference, body weight, and body mass index (BMI).

Interventions

DIETARY_SUPPLEMENTGoode Health Beverage

This is a commercially available beverage powder that is high is healthy ingredients that are believed to be beneficial for physiological health.

DIETARY_SUPPLEMENTVanilla Base Beverage Blend

This is a commercially available beverage powder.

Sponsors

The University of Texas at Arlington
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
PREVENTION
Masking
SINGLE (Investigator)

Masking description

This will be a double-blinded design where the product (experimental of control) will be randomly assigned and given to the participant by a third party individual.

Intervention model description

Individuals will be randomly assigned to either an experimental or a control condition.

Eligibility

Sex/Gender
ALL
Age
18 Years to 55 Years
Healthy volunteers
Yes

Inclusion criteria

* Men and women who are between the ages of 18-55

Exclusion criteria

* Individuals who have donated more than 550 ml of blood within the past 8 weeks will not have blood drawn from them in this protocol. However, if they remain interested in the study, and otherwise meet the inclusion criteria, then we may still opt to proceed with data collection. * Any food allergy. * Pregnant women * Breast feeding * Allergies to spandex/lycra.

Design outcomes

Primary

MeasureTime frameDescription
Endothelial Functionbaseline & following 2 weeks of daily beverage consumptionFlow medicated dilation of the brachial artery
Neurocognitive Functionbaseline & following 2 weeks of daily beverage consumptionPerformance on the NIH Toolbox Cognitive battery
Peripheral blood pressure (systolic, diastolic, mean)baseline & following 2 weeks of daily beverage consumptionstandard blood pressure measures
Lipid profile (Total-C, LDL-C, VLDL-C, HDL-C, TG)baseline & following 2 weeks of daily beverage consumptionassessment of lipid profile

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026